Predictive and prognostic value of circulating tumor cell detection in lung cancer : a clinician's perspective

Annette Tognela, Kevin J. Spring, Therese Becker, Nicole J. Caixeiro, Victoria J. Bray, Po Yee Yip, Wei Chua, Stephanie H. Lim, Paul de Souza

    Research output: Contribution to journalArticlepeer-review

    34 Citations (Scopus)

    Abstract

    There is increasing evidence for the use of circulating tumor cells (CTCs) as a "liquid biopsy" for early detection of lung cancer recurrence, prognosticating disease and monitoring treatment response. Further, CTC molecular analysis and interrogation of single cells hold significant potential in providing insights into tumor biology and the metastatic process. Ongoing research will likely see the translation of CTCs as a prognostic and predictive biomarker in both small cell, and non-small cell, lung cancer to routine clinical practice.
    Original languageEnglish
    Pages (from-to)90-102
    Number of pages13
    JournalCritical Reviews in Oncology/Hematology
    Volume93
    Issue number2
    DOIs
    Publication statusPublished - 2015

    Keywords

    • biomarkers
    • circulating tumour cells
    • lung cancer

    Fingerprint

    Dive into the research topics of 'Predictive and prognostic value of circulating tumor cell detection in lung cancer : a clinician's perspective'. Together they form a unique fingerprint.

    Cite this